Home > Products
Cat. No. Product name CAS No.
DCC3629 Neu-730

Novel inhibitor of TbrPDEB1, showing modest inhibition of T. brucei proliferation

1622300-88-2
DCC3630 Neurodazole

Novel neurogenic inducer for converting pluripotent P19 cells into electrophysiologically active neurons

DCC3631 Neuroprotectant-7

Novel neuroprotectant for Alzheimers disease, showing significant neuroprotection and antioxidative properties, crossing the blood-brain barrier (BBB)

1610504-84-1
DCC3632 Neurotensin(8-13)

The neurotensin active fragment, eliciting behavioral responses typical of clinically used antipsychotic drugs when administered directly to the brain

60482-95-3
DCC3633 Nexturastat A-crbn-12d

Novel potent HDAC6 degrader with promising antiproliferation activity in multiple myeloma (MM) cells

DCC3634 Nfat-133

Inhibitor of NFAT-mediated transcription, leading to the suppression of interleukin-2 expression and T cell proliferation, showing immunosuppressive, antidiabetic, and antitrypanosomal activities

DCC3635 Nf-kappab Inhibitor-2

First-in-class inhibitor of NF-κB signaling pathway by preventing the maturation of a rate-limiting multiprotein complex necessary for IKK activation

DCC3636 N-formyl-met-phe

Neutrophil Dysfunction Test Peptide

22008-60-2
DCC3637 Nfu1827

Novel inhibitor of human cytomegalovirus (HCMV) infection

DCC3638 Ngd 98-2

New generation, topology 2 selective orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist

355836-54-3
DCC3639 Ngd-8243

Novel TRPV1 Antagonist

573678-04-3
DCC3640 Ngd9002

New generation, topology 2 selective corticotropin releasing factor-1 (CRF-1) receptor antagonist

666256-06-0
DCC3641 Ngp1-01

Brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels, acting as chemosensitizer and circumvent the resistance of the plasmodia parasite against chloroquine (CQ) by inhibiting the p-glycoprotein efflux pump and enabling th

33226-57-2
DCC3642 Nh2-bodipy

Novel cell-permeant probe for the super-resolution imaging of the endoplasmic reticulum in live cells

DCC3643 Nh2-nplh2

Novel luciferin analog, enabling both sensitive and highly resolved imaging in vivo

1629640-37-4
DCC3644 Nh2-uamc1110

UAMC1110 Conjugate Linker

DCC3645 Nhi-1j

Selective Inhibitor of Human Lactate Dehydrogenase Isoform A (LDH-A)

1269802-68-7
DCC3646 Nicodicosapent

Novel inhibitor of the sterol regulatory element binding protein (SREBP)

1269181-69-2
DCC3647 Nicofibrate

Antilipidemic agent

31980-29-7
DCC3648 Nifrofam

Novel fluorescent probe for imaging α4β2* nAChRs

DCC3649 Nik-21273

Potent and selective NOP receptor antagonist

DCC3650 Nim811

Cyclophilin inhibitor, showing reduction in interleukin-2 expression and reduction in CNS inflammatory infiltrates, inhibiting HCoV-229E replication

143205-42-9
DCC3651 Ningetinib Tosylate

Novel potent tyrosine kinase inhibitor (TKI), targeting c-Met, VEGFR2 and Axl

1394820-77-9
DCC3652 Niraparib R-enantiomer

Novel potent PARP1 inhibitor

1038915-58-0
DCC3653 Nir-bg2

Novel self-immobilizing near-infrared (NIR) fluorogenic probe that can be activated by senescence-associated ß-galactosidase (SA-ß-Gal), the most widely used senescence marker

DCC3654 Nir-hs

Novel highly selective and sensitive near-infrared fluorescent probe for imaging of hydrogen sulphide in living cells and mice

DCC3655 Nir-ii Fluorophore-h1

Novel precursor of bright-emission NIR-II fluorophores for in vivo tumor imaging and image-guided surgery

DCC3656 Nirluc2

NIR emitting firefly luciferin analogue, displaying dose-independent improved NIR emission even at low concentrations where the native d-luciferin substrate does not emit

DCC3657 Nir-o2

Novel NIR NIR O2˙– probe, displays superior sensitivity to NIR O2˙– and having the capability to monitor trace amounts of intracellular NIR O2˙– in AKI in vivo

DCC3658 Nitd008

Antiviral agent against KFDV, AHFV, OHFV, as well as tick-borne encephalitis virus (TBEV) and mosquito-borne flaviviruses

1044589-82-3
DCC3659 nitro-r-flurbiprofen

Selective modulator of amyloid-beta peptide degradation, regulating Abeta levels

1374330-95-6
DCC3660 Nivocasan

Novel pan-caspase inhibitor, potently reducing not only inflammasome-mediated interleukin-1β (IL-1β) secretion but also osteoclast differentiation in BMMs

908253-63-4
DCC3661 Nizofenone Fumarate

Neuroprotective, protecting neurons from death following cerebral anoxia (interruption of oxygen supply to the brain).

54533-86-7
DCC3662 Nktr-102

Topoisomerase I inhibitor prodrug, slowly hydrolyzing and releasing irinotecan, increasing drug penetration into tumors and decreasing drug clearance

848779-32-8
DCC3663 Nld-22

Novel Enterovirus 71 Inhibitor, binding to the hydrophobic pocket in VP1 to block viral infection, exhibiting excellent antiviral activity (with an EC50 of 5.056 nM and a 100% protection rate for mice at a dose of 20 mg/kg) and low toxicity

DCC3664 Nlrp3 Inhibitor 4b

Novel NLRP3 inhibitor, reducing caspase-1 activation, oligomerization of ASC, and therefore, IL-1β processing, showing a significant anti-inflammatory effect and reduced mechanical hyperalgesia at 3 and 10 mg/kg (i.p.) in an in vivo mouse of gout

DCC3665 Nmac24

Novel Nm23-H1 activator, exerting cytotoxic effects on metastatic breast cancer cells by inducing mitochondrial dysfunction only under glucose starvation

DCC3666 nmda167-3

Novel inhibitor of the Gli1 transcription, inducing apoptosis in cancer cells but not in non-cancerous cells

1239447-58-5
DCC3667 Nmda298-1

Novel inhibitor of glioma-associated oncogene homologue 1 (Gli1) mediated transcription

DCC3668 Nmdi14

Novel Inhibitor of Nonsense-Mediated RNA Decay, Suppressing Nonsense p53 Mutations

307519-88-6
DCC3669 N-me-aminopyrimidinone 9

Potent and state-dependent Nav1.7 antagonist

1356834-62-2
DCC3670 Nmi801

Novel Mdm2 inhibitor, acting as a negative regulator of p53, reducing viability in cell culture and suppressing tumor growth

DCC3671 nmk-td-100

Novel Microtubule Modulator, Blocking Mitosis and Inducing Apoptosis in HeLa Cells by Binding to Tubulin

1252802-38-2
DCC3672 nms859

Covalent and allosteric inhibitor of the ATPase VCP/p97, inducing cancer cell death

1449236-96-7
DCC3673 Nms-p715 Analog

Novel selective and orally bioavailable MPS1 inhibitor

1202055-34-2
DCC3674 Nms-p953

Novel JAK2 inhibitor, displaying significant tumor growth inhibition in SET-​2 xenograft tumor model, with a mechanism of action confirmed in vivo by typical modulation of known biomarkers, and with a favorable pharmacokinetic and safety profile

1403679-33-3
DCC3675 Nn9056

Novel Potent and Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor (CCK-1R) Agonist

DCC3676 N-n-butyl Haloperidol Iodide

Novel inhibitor of autophagy, protecting cardiomyocytes against hypoxia/reoxygenation injury

DCC3677 Nnc-38-1049

Novel selective histamine H3 antagonist

757183-18-9
DCC3678 Nn-dnj

Iminosugar, binding to the active site of lysosomal beta-glucosidase and stabilizing the proper folding for the catalytic form, acting as a chemical chaperone that facilitate transport and maturation of acid beta-Glu

81117-35-3
DCC3679 Nnmt Inhibitor Ns1

Novel potent alkynyl bisubstrate inhibitor of nicotinamide N-methyltransferase (NNMT)

DCC3680 nnrti F2

Novel non-nucleoside reverse transcriptase inhibitor (NNRTI)

1152034-94-0
DCC3681 Nocardicin A

Moderate antibiotic agent against a broad spectrum of gram-negative bacteria

39391-39-4
DCC3682 Nocardicin G

The universal precursor of the nocardicins

65309-11-7
DCC3683 Nocathiacin I

Natural Inhibitor of an Oncogenic RNA, targeting RNA folds in the nuclease processing site in the oncogenic, noncoding microRNA-18a, selectively inhibiting nuclease processing in vitro and in prostate cancer cells and triggering apoptosis

214044-52-7
DCC3684 nocazine C

Nocazine family member

1421460-89-0
DCC3685 nocazine E

Marine natural nocazine family member; Standard used in nocazine biosynthetic parthway studies

1421460-90-3
DCC3686 Nociceptin

Neuropeptide, acting as a endogenous ligand for the nociceptin receptor (NOP, ORL-1)

170713-75-4
DCC3687 N-oleoylethanolamine

PPARalpha agonist and EC 3.5.1.23 (ceramidase) inhibitor

111-58-0
DCC3688 Nomegestrol

Steroidal progestin

58691-88-6
DCC3689 Nomegestrol Acetate

Neutral, nonandrogenic, progesterone-like profile progestin

58652-20-3
DCC3690 Nonoxynol-9

Novel human epidermal growth factor receptor-2 (HER2) inhibitor; Spermatocide

26571-11-9
DCC3691 Nord-1

Novel red-light-controllable nitric oxide (NO) releaser

DCC3692 Nor-fauc-365

FAUC-365 analog

DCC3693 Norgestomet

Steroidal progestin used in veterinary medicine to control estrus and ovulation in cattle

25092-41-5
DCC3694 Noricumazole A

Secondary metabolite from the myxobacterium Sorangium cellulosum, acting as a potent HCV inhibitor, Ebola virus (EBOV) entry inhibitor, and a potassium channel inhibitor

DCC3695 No-rosa5

Controllable nitric oxide (NO) donor, releasing NO triggered by photoinduced electron transfer (PeT)

DCC3696 Noscapine

Natueal sigma receptor agonist, attenuating cytokine release associated with SARS-CoV-2, also being used as anti-malarial, anti-stroke and cough-suppressant

128-62-1
DCC3697 Notum-in-23dd

Novel potent inhibitor of notum carboxylesterase activity

DCC3698 Notum-in-24

Novel potent notum inhibitor (OPTS IC50 3.6nM; TCF-LEF EC50 220nM), showing good plasma exposure and reasonable CNS penetration

DCC3699 Nov-lrrk2-11

Novel potent LRRK2 inhibitor

DCC3700 Novolactone

Natural inhibitor of the allosteric regulation of Hsp70

1804950-46-6
DCC3701 Np-005497

Natural inhibitor of jasmonate signaling targets JAR1 in Arabidopsis thaliana

DCC3702 Npa101.3

Second-Generation RET/VEGFR2 Inhibitor

1839155-15-5
DCC3703 Np-c86

Novel stabilizer of long noncoding RNA (lncRNA) GAS5, binding to GAS5 with high affinity, and increasing GAS5 levels and glucose uptake in diabetic patient adipocytes

DCC3704 Npd-008

Novel Inhibitor of Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1)

2229043-42-7
DCC3705 Npd-039

Novel Inhibitor of Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1)

2229043-40-5
DCC3706 Npd-048

Novel inhibitor of Trypanosoma brucei PDEB1 (TbrPDEB1)

DCC3707 Npd11033

Novel selective SIRT2 inhibitor, creating a hydrophobic cavity behind the substrate-binding pocket after a conformational change of the Zn-binding small domain of SIRT2

DCC3708 Npd12671

Novel activator of 15-ADON production, significantly increasing the transcription of Tri6, a transcription factor gene necessary for trichothecene biosynthesis, in both trichothecene-inducing and noninducing culture conditions

865282-76-4
DCC3709 Npd2639

Novel biomediator, inducing reveromycin production in Streptomyces sp. SN-593

859130-76-0
DCC3710 Npd6689

Novel tubulin inhibitor

859671-40-2
DCC3711 Npd7155

Novel competitive MTH1 inhibitor

924764-38-5
DCC3712 Npd8617

Novel tubulin inhibitor

313481-28-6
DCC3713 Npd9055

Novel heterotrimeric G-protein Gi modulator, inhibiting GDP/GTP exchange on a Gαi subunit induced by a G-protein-coupled receptor agonist, but not on another G-protein from the Gαs family, regulating Gβγ-dependent cellular processes, most likely by causin

327102-63-6
DCC3714 Nplc0393

Novel inhibitor of TGF-β1 signaling pathway, inhibiting the upregulation of MAT2A mechanistically, dose-dependently activating PP2Cα and efficiently alleviating liver fibrosis

862286-45-1
DCC3715 Npr-c Activator 1

Novel potent activator of the natriuretic peptide receptor C (NPR-C) with EC 50 ~1 μM

DCC3716 Nps-89636

Calcilytic negative allosteric modulator of calcium-sensing receptor (CaR)

1588949-48-7
DCC3717 Nqo1 Substrate 1

Novel substrate for NAD(P)H: quinone oxidoreductase 1 (NQO1), acting as an effective intracellular ROS generator for the treatment of drug-resistant non-small-cell lung cancer

2304503-05-5
DCC3718 Nr2b-in-1

Novel NMDA/NR2B Antagonist

913574-42-2
DCC3719 Nrf2/ho-1 Activator Ll202

Novel activator of the Nrf2/HO-1 pathway, upregulating heme oxygenase-1 (HO-1) via promoting nuclear translocation of nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) to regulate LPS‐induced oxidative stress in macrophages

DCC3720 Nrf2-activator Featured

Nrf2-Activator is a potent Nrf-2 activator.

1554271-18-9
DCC3721 Ns-0011

Novel inhibitor of CDK5 translocation, increasing CDK5 accumulation in the nucleus, suppressing both cancer cell proliferation and xenograft tumorigenesis.

1076234-33-7
DCC3722 Ns-2710

Potent, non-selective partial agonist at GABAA receptors with little efficacy at the alpha1 subtype and more at alpha2 and alpha3

184220-36-8
DCC3723 ns3/4a-in-12

Novel Inhibitor with Activity against NS3/4A proteases from Multiple Hepatitis C Virus Genotypes

DCC3724 ns3-in-5

Novel allosteric inhibitor of HCV NS3 protein function

1434713-38-8
DCC3725 Ns4591

Novel molulator of SK-IK channels [small- and intermediate-conductance Ca2(+) -activated K(+) channels]

273930-52-2
DCC3726 Ns-6740

Novel potent α7 nAChR partial agonist

753499-14-8
DCC3727 Ns-6784 Hydrochloride

Novel α7 nAChR agonist at human and rat receptors

677723-97-6
DCC3728 Nsc10010

Novel potent growth inhibitor for gammaherpesvirus-associated B-lymphomas through activation of both the NF-κB and c-Myc-mediated signaling pathways

6286-09-5
DCC3729 Nsc1008

Novel Inhibitor of the Ras Converting Enzyme 1 (Rce1) Protease, Disrupting Ras Membrane Localization in Human Cells

5335-95-5
DCC3730 Nsc-100874

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

1135059-20-9
DCC3731 Nsc1011

Ras converting enzyme 1 (Rce1) inhibitor

5335-97-7
DCC3732 Nsc103054

Novel inhibitor of ABCG2 transporter function

19590-55-7
DCC3733 Nsc-104999

Ligand of the Grb7 SH2 domain, inhibiting the growth of MDA-MB-468 cancer cells

1118745-14-4
DCC3734 Nsc107392

Novel substrate of ABCG2

19494-89-4
DCC3735 Nsc109131

Inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1)

21170-27-4
DCC3736 Nsc109779

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

DCC3737 Nsc114792

Novel selective inhibitor of JAK3

17392-79-9
DCC3738 Nsc-117199

Selective inhibitor of shp2 protein tyrosine phosphatase (PTP)

21303-44-6
DCC3739 Nsc-12404

Selective non-lipid agonist of LPA2/3

5411-64-3
DCC3740 Nsc-126188

Apoptosis inducer; Antitumor agent

31863-82-8
DCC3741 Nsc127133

Novel inhibitor of the second bromodomain (BD2) of the BET family protein BRD2

DCC3742 Nsc-13030

Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines

5442-51-3
DCC3743 Nsc-134754

HIF-pathway inhibitor

75041-32-6
DCC3744 Nsc13987

Novel inhibitor of Nef-calnexin interaction

81-94-7
DCC3745 Nsc-140873

Inhibitor of the RUNX1-CBFβ interaction

106410-13-3
DCC3746 Nsc16168

Specific inhibitor of ERCC1-XPF with no effect on both HhaI and XPG

6837-93-0
DCC3747 Nsc175176

Novel potent and selective serotonin reuptake inhibitor (SSRI)

DCC3748 nsc-176327

Selective G-quadruplex inducer of the human telomeric sequence; Stabilizer of the G-quadruplex formed by the MYC promoter sequence; Anti-neoplastic effects in wild-type p53, p53-mutant or p53-deficient human colon cancer cells.

85632-83-3
DCC3749 Nsc-176377

Non-nucleoside reverse transcriptase inhibitor

20841-26-3
DCC3750 Nsc-18725

Novel inhibitor of growth of intracellular Mycobacterium tuberculosis, inducing autophagy in differentiated THP-1 macrophages

715-99-1
DCC3751 nsc-20596

Capturer of kinase-insertion domain receptor (KDR) from a solution, while allowing the captured KDR to bind with the solution-phase vascular endothelial growth factor (VEGF)

6976-14-3
DCC3752 Nsc24048

Novel inhibitor of ABCG2 transporter function

5459-47-2
DCC3753 Nsc-24198

Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines

7152-78-5
DCC3754 Nsc24674

Novel 3C-like protease inhibitor of SARS-CoV-2

DCC3755 Nsc-2488 [5459-61-0]

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

5459-61-0
DCC3756 nsc-252359

Specific Ligand for Stem Loop 3 Ribonucleic Acid of the Packaging Signal Ψ of Human Immunodeficiency Virus-1

500889-59-8
DCC3757 Nsc265473

Novel substrate of ABCG2

61786-74-1
DCC3758 Nsc-279287

Novel Inhibitor of the p53-mdm2 Interaction, Activating p53-Dependent Transcription in mdm2-Overexpressing Cells

59541-35-4
DCC3759 Nsc-2888

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

5335-14-8
DCC3760 Nsc-299202

Novel potent gonist of Human G Protein-Coupled Receptor-35 (hGPR35) (EC50 8 nM)

49635-47-4
DCC3761 Nsc30049

Novel inhibitor of Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations

DCC3762 Nsc-311068

Novel selective inhibitor of TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, effectively inhibiting cell viability in AML with high expression of TET1

73768-68-0
DCC3763 Nsc-33353

Potent inhibitor of the AcrAB-TolC efflux pump in Escherichia coli, potentiating the antibacterial activities of novobiocin and erythromycin upon binding to the membrane fusion protein AcrA

DCC3764 Nsc-339579

Novel potent Mycobacterium tuberculosis DHFR inhibitor

65795-53-1
DCC3765 Nsc339614 Potassium Salt

Selective potentiator at GluN1/GluN2C and GluN1/GluN2D receptors

1135037-53-4
DCC3766 Nsc-347518

DT-diaphorase inhibitor

87626-58-2
DCC3767 Nsc-4231

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

5397-55-7
DCC3768 nsc48693 Dihydrochloride

Potent apoptosis inducer in pancreatic cancer cells

1356084-90-6
DCC3769 Nsc52101

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

DCC3770 Nsc-55158

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

5507-11-9
DCC3771 Nsc56452

Novel specific inhibitor of EGF receptor autophosphorylation and cell proliferation in HeLa cells by disrupting allosteric activation of EGF-stimulated dimer

DCC3772 Nsc-57148

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

4315-44-0
DCC3773 Nsc-57774

Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines

524-11-8
DCC3774 Nsc57971

Novel non-peptide disruptor of IKKß/NEMO complex

6632-11-7
DCC3775 Nsc-60339

Novel efflux pump inhibitor (EPI)

70-09-7
DCC3776 Nsc61610

Novel activator of lanthionine synthetase C-like 2 (LANCL2), down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and reduction in the infiltration of neutrophils, accelerating recovery and inducing IL-10-mediated regulator

500538-94-3
DCC3777 Nsc-627757

Novel DNA repair inhibitor

DCC3778 Nsc636795

Novel inhibitor of ABCG2 transporter function

66528-28-7
DCC3779 Nsc-657186

Novel selective non-zinc-binding MMP-2 inhibitor

1772-39-0
DCC3780 Nsc65847

Novel dual inhibitor of viral and Streptococcus pneumoniae neuraminidase

6949-15-1
DCC3781 Nsc66098

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

3259-43-6
DCC3782 Nsc663627

IκBα phosphorylation inhibitor

51837-75-3
DCC3783 Nsc-670224

Toxitant of Saccharomyces_cerevisiae>Saccharomyces cerevisiae

1374648-47-1
DCC3784 Nsc-672121

Potent CDC25A>Cdc25A inhibitor; Vitamine K3 analogue

59147-84-1
DCC3785 Nsc-674205

Potent and selective nociceptin opioid receptor (NOP) agonist

13130-47-7
DCC3786 Nsc676914a

Novel NF-κB inhibitor

DCC3787 nsc-681152

Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27(Kip1) ubiquitination in vitro

241128-06-3
DCC3788 Nsc-689857

Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27Kip1 ubiquitination in vitro

241127-79-7
DCC3789 Nsc704342

Novel Inhibitor of HCV NS3/4A Proteinase

DCC3790 Nsc705841

Novel selective serotonin reuptake inhibitor (SSRI), exhibiting higher binding affinities in comparison with the paroxetine

DCC3791 Nsc724526

Novel Inhibitor of HCV NS3/4A Proteinase

DCC3792 Nsc724527

Novel Inhibitor of HCV NS3/4A Proteinase

DCC3793 Nsc-73306

Cytotoxic MDR-selective ligand

79560-74-0
DCC3794 Nsc-741909

Novel anticancer agent, suppressing the growth of several cell lines derived from lung, colon, breast, ovarian, and kidney cancers

92407-91-5
DCC3795 Nsc745885

Novel down-regulator of EZH2, inducing G2/M cell-cycle arrest of cancer cells and degradating p53 via proteasome-dependent and -independent pathways

4219-52-7
DCC3796 nsc746364

Telomerase inhibitor, stabilizing G-quadruplex and suppressing cell growth of A549 human lung cancer cells through activation of the ATR/Chk1-dependent pathway

1190593-30-6
DCC3797 nsc746365 Maleate

Telomerase inhibitor, anticancer agent

209176-53-4
DCC3798 Nsc747854

Novel inhibitor of poly (ADP-ribose) polymerase-1 (PARP-1)

1329520-12-8
DCC3799 Nsc750212

Novel inhibitor of lipid metabolism, disrupting tubulin polymerization,suppressing monoglycerol metabolism depleting lipids and inhibiting the growth of both lymphoma and RCC both in vitro and in vivo

DCC3800 Nsc-77053

The first reported BoNT/E small molecule inhibitor

77308-57-7
DCC3801 Nsc-79887

Novel inhibitor of nucleoside hydrolase (NH)

19056-78-1
DCC3802 Nsc-80141

Selective inhibitor of HsEg5

97027-56-0
DCC3803 Nsc-84096

Potent inhibitor of endopeptidase activity of botulinum neurotoxin type A light chain (rBoNT/A-LC)

908813-78-5
DCC3804 Nsc-8891

Tyrosyl-DNA phosphodiesterase (Tdp1) inhibitor

21170-34-3
DCC3805 Nsc-9037

First-in-class probe of Rad6 function, inhibiting Rad6 function and Rad6-Rad18 interaction in the PCNA ubiquitination cascade

3569-82-2
DCC3806 nsc-96626

Novel B-Raf(V600E) inhibitor

27430-18-8
DCC3807 Nsi-189 Phosphate

Novel stimulator of neurogenesis of human hippocampus-derived neural stem cells in vitro and in vivo.

1270138-41-4
DCC3808 Nsmase2-in-1

Novel inhibitor of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseases

DCC3809 Nsp-116

Novel free radical scavenger, against light-induced photoreceptor cell damage

DCC3810 Nti-007

Potent anti-HBV agent, targeting the NTCP-APOA1-HBx-Beclin1-mediated autophagic pathway

DCC3811 Ntrc-739

Novel nonpeptide selective ligand for NTS2

DCC3812 Ntrc-808

Novel nonpeptide potent and selective partial agonist of the Neurotensin receptor type 2 (NTS2)

DCC3813 Ntrd22

Novel Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43

DCC3814 Ntr-responsive Protac 17-1

The first NTR-responsive PROTAC, incorporating the caging group on the Von Hippel-Lindau (VHL) E3 ubiquitin ligase ligand, efficiently degrading the EGFR protein and subsequently exert antitumor efficacy

DCC3815 Ntz-15

Novel potent STAT3 inhibitor, exhibiting much improved in vivo pharmacokinetic parameters in rats and efficacies against proliferations in multiple cancer cell lines

DCC3816 Ntz-24

Novel potent STAT3 inhibitor

69819-42-7
DCC3817 Ntzdpa

Novel potent and selective non-thiazolidinedione partial Peroxisome_proliferator-activated_receptor>PPARγ agonist, acting as an antibiotic effectively against bacterial persisters

118414-59-8
DCC3818 Nu6155

Novel potent CDK2 inhibitor

DCC3819 Nuc013

Novel DNA methytransferase inhibitor, be significantly safer and more effective than decitabine in xenograft models of human leukemia and colon cancer

DCC3820 Nucc-201177

Novel highly potent and selective MEK4 inhibitor

DCC3821 Nucc-474

Novel potent activin antagonist

DCC3822 Nucc-555

First-in-class activin antagonist, specifically binding to ALK4, which opens a completely new approach to inhibiting the activity of TGF-beta receptor superfamily members

1060469-90-0
DCC3823 Nucleocidin

Nucleosidic antibiotic

24751-69-7
DCC3824 Nuod-in-25

Novel inhibitor of Helicobacter pylori , targeting H. pylori's respiratory complex I subunit NuoD

DCC3825 Nurf Inhibitor Bz1

Novel Potent Cell-Active Inhibitor of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition

DCC3826 Nusb-nuse Inhibitor-22

Novel Inhibitor of the NusB-NusE Protein-Protein Interaction with Antibiotic Activity

DCC3827 Nusb-nuse Interaction Inhibitor-1

Novel modulator of the NusB-NusE interaction

125966-81-6
DCC3828 Nutlin-1

p53-MDM2 binding inhibitor; p-Glycoprotein (p-gp) transport substrate; Antitumer agent

548472-58-8
<Prev1...184185186187188...215Next>